← Browse by Condition
Medical Condition

primary central nervous system hodgkin lymphoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT04961515 Phase 2
Recruiting

Orelabrutinib, Sintilimab and Temozolomide in Relapsed or Refractory Central Nervous System Lymphoma

Enrollment
19 pts
Location
China
Sponsor
Second Affiliated Hospital, Sc...
View Trial →